Kinfo
Adagio Therapeutics, Inc. logo

Adagio Therapeutics, Inc.

ADGINASDAQ·US · USD
$0.80
-0.03 (-3.13%)
Prices as of July 9, 2026 · market closed

Price

Key statistics

Valuation
Market cap0.00 USD
Enterprise value0.00 USD
Trailing P/E-0.15
Forward P/E-2.34
PEG ratio0.00
Price / sales0.00
Price / book0.19
Profitability
Gross margin0.00%
Operating margin0.00%
Profit margin0.00%
Return on assets-36.57%
Return on equity77.64%
Income (TTM)
Revenue0.00 USD
Gross profit0.00 USD
EBITDA0.00 USD
Net income-226.79M USD
Diluted EPS-$5.32
Rev. growth (YoY)0.00%
Balance sheet
Total cash0.00 USD
Total debt2.86M USD
Debt / equity-0.01
Current ratio31.55
Book value / share-$4.10
Cash flow (TTM)
Operating cash flow-214.63M USD
Levered free cash flow-226.79M USD
Shares & price
Shares outstanding42.62M
Float0.00
Held by institutions0.00%
Beta0.00
50-day MA$0.00
200-day MA$0.00
52-week high$3.07
52-week low$0.48
Earnings (EPS)
DateEst.ActualSurprise2022-08-15-0.57-0.47+17.54%2022-05-13-0.82-0.93−13.41%2022-03-30-1.03-0.77+25.24%2021-11-15-0.74-0.98−32.43%2021-09-20-0.80-0.18+77.50%

Frequently asked questions about Adagio Therapeutics, Inc.